Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Gili

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Thrombosis Research|June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registryCarme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
International Journal of Cardiology|July 13, 2016
Impact of blood transfusion on in-hospital myocardial infarctions according to patterns of acute coronary syndrome: Insights from the BleeMACS registrySebastiano Gili, Fabrizio D'Ascenzo, Marco Francesco Lococo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS RegistriesMattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
American Heart Journal|December 7, 2019
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registriesFabrizio D'Ascenzo, Carloalberto Biolè, Sergio Raposeiras-Roubin, et al.
Journal of the American Heart Association|July 18, 2019
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo RegistryVictoria L Cammann, Annahita Sarcon, Katharina J Ding, et al.
Journal of the American College of Cardiology|August 18, 2018
Long-Term Prognosis of Patients With Takotsubo SyndromeJelena R Ghadri, Ken Kato, Victoria L Cammann, et al.
European Journal of Heart Failure|December 22, 2019
Impact of aspirin on takotsubo syndrome: a propensity score-based analysis of the InterTAK RegistryFabrizio D'Ascenzo, Sebastiano Gili, Maurizio Bertaina, et al.
European Heart Journal|May 18, 2019
Cardiac arrest in takotsubo syndrome: results from the InterTAK RegistrySebastiano Gili, Victoria L Cammann, Susanne A Schlossbauer, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Thrombosis Research|June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registryCarme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
International Journal of Cardiology|July 13, 2016
Impact of blood transfusion on in-hospital myocardial infarctions according to patterns of acute coronary syndrome: Insights from the BleeMACS registrySebastiano Gili, Fabrizio D'Ascenzo, Marco Francesco Lococo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS RegistriesMattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
American Heart Journal|December 7, 2019
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registriesFabrizio D'Ascenzo, Carloalberto Biolè, Sergio Raposeiras-Roubin, et al.
Journal of the American Heart Association|July 18, 2019
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo RegistryVictoria L Cammann, Annahita Sarcon, Katharina J Ding, et al.
Journal of the American College of Cardiology|August 18, 2018
Long-Term Prognosis of Patients With Takotsubo SyndromeJelena R Ghadri, Ken Kato, Victoria L Cammann, et al.
European Journal of Heart Failure|December 22, 2019
Impact of aspirin on takotsubo syndrome: a propensity score-based analysis of the InterTAK RegistryFabrizio D'Ascenzo, Sebastiano Gili, Maurizio Bertaina, et al.
European Heart Journal|May 18, 2019
Cardiac arrest in takotsubo syndrome: results from the InterTAK RegistrySebastiano Gili, Victoria L Cammann, Susanne A Schlossbauer, et al.
Pageof 10